Abstract
Between September 1994 and October 1995, we diagnosed and treated four cases of early onset posttransplantation lymphoproliferative disorder (PTLD) occurring within 62 days of pancreas transplantation. The development of PTLD was associated with both a significantly higher total muromonab-CD3 (OKT3) dose and a lack of ganciclovir/acyclovir prophylaxis, but it was not associated with the total dose of antithymocyte globulin or cytomegalovirus serostatus. All four patients were treated aggressively and survived without evidence of recurrent PTLD more than 1.5 years later. We conclude that the use of a high total dose of OKT3 puts pancreas transplant recipients at increased risk for early onset PTLD, while ganciclovir/acyclovir prophylaxis may help to prevent this disorder; however, if early onset PTLD does occur in these patients, aggressive therapy can lead to a favorable outcome.
Citations
Dec 31, 1998·Springer Seminars in Immunopathology·M A Nalesnik
Dec 31, 1998·Springer Seminars in Immunopathology·C L Davis
Mar 29, 2013·Nature Reviews. Drug Discovery·Jean G SathishB Kevin Park
Oct 31, 2002·Surgery·Joseph F BuellE Steve Woodle
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J K Preiksaitis, S Keay
Apr 17, 2001·Annals of Surgery·D E SutherlandJ S Najarian
Dec 14, 2004·Transplantation·Christopher G A McGregorJohn S Logan
Sep 24, 2005·Transplantation·Steven ParaskevasRainer W G Gruessner
Mar 30, 2006·Transplantation·Atul HumarUpton Allen
Jan 11, 2000·AJR. American Journal of Roentgenology·T L MeadorS Bartlett
Nov 11, 2014·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Juan C CamachoPardeep K Mittal
Jan 18, 2011·Hematology/oncology Clinics of North America·Kevin Shiley, Emily Blumberg
May 15, 2010·Infectious Disease Clinics of North America·Kevin Shiley, Emily Blumberg
Mar 22, 2006·Transplantation Proceedings·A TimurağaoğluA Demirbaş
Feb 10, 2012·Clinical & Developmental Immunology·Debora MartorelliRiccardo Dolcetti
Oct 6, 2006·American Journal of Hematology·Francis K BuadiClarence Sarkodee-Adoo
Feb 8, 2005·Xenotransplantation·Sumeet S TeotiaChristopher G A McGregor
Jan 11, 2003·Clinical and Diagnostic Laboratory Immunology·Frank J JenkinsCharles R Rinaldo
Feb 18, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·David A BaranAlan L Gass
May 26, 2018·Current Treatment Options in Oncology·Ajay Major, Manali Kamdar